Examkin

Question

Difficulty: HardDiagnostic Testing Performance

A medical advisory board for a high-risk gastroenterology clinic is refining the screening protocol for cholangiocarcinoma using a novel continuous serum assay. Elevated assay levels correlate closely with the presence of disease. Initial guidelines placed the diagnostic threshold at the 95th percentile of asymptomatic controls. However, because delayed detection of this malignancy leads to near-universal mortality, the board modifies the protocol to explicitly minimize the incidence of Type II errors. What is the most likely statistical consequence of modifying this threshold?

  1. The probability that a patient with a negative test actually has the malignancy will decrease.Answer
  2. B
    The probability that a patient with a positive test actually has the malignancy will increase.
  3. C
    The proportion of true negative results among all patients without the malignancy will increase.
  4. D
    The false discovery rate of the screening assay will decrease.
  5. E
    The area under the receiver operating characteristic (ROC) curve will increase.

Answer

The probability that a patient with a negative test actually has the malignancy will decrease.
The medical advisory board seeks to minimize Type II errors, which correspond directly to false-negative results. To achieve this, the test's sensitivity must be maximized by lowering the diagnostic threshold. When the threshold is lowered, more patients cross the line to test positive. This simultaneously decreases the number of false negatives and increases the number of false positives. Negative Predictive Value (NPV) is defined as the proportion of negative results that are true negatives, calculated as TN / (TN + FN). Because the threshold adjustment deliberately minimizes false negatives (the denominator), the NPV increases. The false omission rate is the mathematical complement of NPV (1 - NPV) and represents the probability that a patient with a negative test actually has the disease. Because NPV increases, this specific probability decreases, ensuring fewer cases of cholangiocarcinoma are missed.

Step-by-Step Solution

1
Identify the clinical meaning of a Type II error in this diagnostic context.
A Type II error represents a false-negative result (failing to detect the malignancy when present).
Understanding the clinical goal requires translating it into standard epidemiological terminology.
2
Determine the parameter shift required to minimize false negatives.
To decrease false-negative results, the test's sensitivity must be maximized by lowering the diagnostic cutoff threshold.
Lowering the cutoff threshold captures more true positive cases, though it inherently sacrifices specificity.
3
Analyze the impact of lowering the cutoff on predictive values.
Lowering the cutoff decreases false negatives and increases false positives. Consequently, the Negative Predictive Value (NPV) increases, while the Positive Predictive Value (PPV) decreases.
NPV is calculated as TN / (TN + FN). As FN approaches zero, NPV approaches 100%.
4
Evaluate the answer choices against these statistical shifts.
The probability that a patient with a negative test has the disease is the False Omission Rate (1 - NPV). Since NPV increases, this probability must decrease.
This confirms the correct option.

Key Concept

Minimizing Type II errors (false negatives) requires lowering the diagnostic threshold, which increases test sensitivity and negative predictive value (NPV) while decreasing specificity and positive predictive value (PPV).
Estimated Time:1m 30s
Rate this question

Topics

Diagnostic Testing Performance

More questions from this topic